Debiopharm Galenic Unit Company Profile

20:30 EDT 22nd September 2017 | BioPortfolio

Debiopharm, Debiovision, Debioinnovation, Debio R.P. and Debioclinic form an established group of five complementary and synergistic companies. Together, they provide drug development expertise and know-how from evaluation of early-stage and innovative research, formulation, pre-clinical and clinical trials, global registration, financing, partnering to manufacturing and sophisticated drug-delivery systems in North America, Canada, Europe and Japan.


14, Rte des Avouillons
CH - 1196


Phone: 41 (0) 22 354 88 88
Fax: 41 (0) 22 354 88 89

News Articles [414 Associated News Articles listed on BioPortfolio]

Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen

Tuesday, May 23rd 2017 at 8:01pm UTC Transaction adds innovative clinical-stage program to expanding Debiopharm portfolio and broadens its clinical development expertise Divestiture aligns with Immuno...

Debiopharm gets ADC candidate from ImmunoGen

ImmunoGen Inc. granted Debiopharm International SA all rights to its anti-CD37 antibody-drug conjugate IMGN529 (naratuximab emtansine) for B-cell malignancies. Debiopharm, which gains its first ADC pr...

Almac Discovery y Debiopharm International SA anuncian el desarrollo de un nuevo inhibidor Wee-1

Almac Discovery (, una compañía biofarmacéutica centrada en el descubrimiento e identificación de terapéuticos innovadores para el tratamiento del cáncer, ...

Debiopharm gains rights to a novel Wee-1 inhibitor program

Almac Discovery has entered into a collaboration with Debiopharm International on the development of…

Debiopharm moves into antibody-drug conjugates acquiring Ph II assets

Debiopharm has acquired ImmunoGen’s IMGN529/DEBIO1562, a clinical-stage anti-CD37 ADC for the treatment…

ImmunoGen sells off ADC to Debiopharm

Debiopharm moves into antibody-drug conjugates as it buys ImmunoGen’s IMGN529 in a $55 million deal.

Debiopharm Acquires Wee-1 Kinase Inhibitor Program from Almac Discovery

Swiss biopharma Debiopharm International negotiated global rights to Almac Discovery’s Wee-1 kinase inhibitor program. The deal gives Debiopharm exclusive rights to Almac Discovery’s Wee-1 patent ...

#news #biotech Debiopharm buys ImmunoGen ADC to grow cancer pipeline

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Debiopharm buys ImmunoGen ADC to grow cancer pipeline .Debiopharm has bought ...

PubMed Articles [762 Associated PubMed Articles listed on BioPortfolio]

Topical therapy of the scalp.

Various hair-related diseases, systemic dermatoses as well as parasitic diseases are treated via topical application of active substances. The density of hair follicles and the consequential special c...

Trauma unit attendance: Is there a relationship with weather, sporting events and week/ month-end times? An audit at an urban tertiary trauma unit in Cape Town.

The Groote Schuur Hospital Trauma Unit is a high-volume referral center where patient volumes may be related to temporal and environmental factors.

Accuracy and mechanical performance of passivated and conventional fabricated 3-unit fixed dental prosthesis on multi-unit abutments.

The aim of this study was to evaluate the fit and mechanical stability of conventional versus passive fitting 3-unit fixed dental prosthesis (FDP) screw-retained on implants.

A comparative study of patients' activities and interactions in a stroke unit before and after reconstruction-The significance of the built environment.

Early mobilization and rehabilitation, multidisciplinary stroke expertise and comprehensive therapies are fundamental in a stroke unit. To achieve effective and safe stroke care, the physical environm...

When selecting a cord blood unit from a firstborn donor verify that the patient shares an Ag with the unit that is foreign to the mother of the donor.

Clinical Trials [1093 Associated Clinical Trials listed on BioPortfolio]

Behavior of Various Galenic Forms of a Probiotic in the Digestive Tract.

The aim of this study is to assess the behavior of a model probiotic strain, Lactobacillus salivarius, in the digestive tract of healthy volunteers and of ileostomized patients, depending ...

HRME: Screening for Cervical Cancer and Its Precursors in Low‐Resource Settings

A new mobile diagnostic and treatment unit is being developed by BCH to address the loss-to follow-up associated with the mobile screening program and demonstrate POC diagnosis by HRME. Th...

A New Clinical Pathway for Patients With Fractured Neck of Femur

The intention is to evaluate the effectiveness of a multi-factorial medical treatment of patients with hip fractures in a specially designed unit for elderly hip fracture patients (orthoge...

Comparison of Tramadol Orally Versus an Optimized Dose of Intravenous Tramadol for Postoperative Pain Relief in Ambulatory Surgery

The purpose of this study is to compare the administration of 1 unit dose of 50 mg tramadol perorally given in 3 unit dosages versus tramadol IV given in 3 unit dosage of 35 mg during the ...

A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy

In this study two cord blood collections will be used to increase the number of cord blood cells you will receive on transplant day. We call this a "double unit" cord blood transplant. A p...

Companies [314 Associated Companies listed on BioPortfolio]

Debiopharm Galenic Unit

Debiopharm, Debiovision, Debioinnovation, Debio R.P. and Debioclinic form an established group of five complementary and synergistic companies. Together, they provide drug development expertise and kn...

The Debiopharm Group

Debiopharm Group(TM) (Debiopharm) is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. The group in-l...

UNIT design collective

UNIT design collective is a multidisciplinary design firm specializing in branding strategy and brand awareness. Comprised of designers, analysts and copywriters - and led by talented creative directo...

University of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit

Perinatal HIV Research Unit

The Perinatal HIV Research Unit (PHRU), established in 1996, is one of the largest AIDS research centres in Africa. The early research focus on prevention of mother to child transmission has expanded ...

More Information about "Debiopharm Galenic Unit" on BioPortfolio

We have published hundreds of Debiopharm Galenic Unit news stories on BioPortfolio along with dozens of Debiopharm Galenic Unit Clinical Trials and PubMed Articles about Debiopharm Galenic Unit for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Debiopharm Galenic Unit Companies in our database. You can also find out about relevant Debiopharm Galenic Unit Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record